Global Healthcare Innovation Summit

The Global Healthcare Innovation Summit returns as the flagship convening of Future Health – A Global Initiative, led by Canadian and international partners.

The Summit brings together senior global decision-makers responsible for healthcare strategy, public policy, investment, and system transformation. Over two days, leaders from biotech, pharma, government, academia, healthcare systems, and capital markets will convene to address the most urgent challenges and transformative opportunities shaping the future of healthcare.

2026 Program Highlights

• Cell Therapy
  Cutting-edge CAR-T and antigen-specific T-cell therapies, with a focus on what is truly advancing into the clinic.

• Bispecifics & Multispecifics
  Emerging T-cell engagers and next-generation antibody platforms for solid tumours and autoimmune disease.

• Therapeutic mRNA Vaccines
  Real-world progress in vaccine design, immunogenicity, manufacturing, and scale-up.

• Radiopharmaceutical Innovation
  Advances in targeted diagnostics and therapeutic applications.

• AI in Drug Discovery & Development
  Using artificial intelligence to accelerate timelines, reduce risk, and improve clinical success.

• Canada–UK Biotech Symposium
  Strengthening transatlantic collaboration, partnerships, and investment pathways.

• Non-Dilutive Funding for Biotech
  Government, institutional, and strategic funding mechanisms supporting innovation.

• Venture Capital Outlook for Life Sciences
  Current funding trends, market dynamics, and emerging opportunities.

• Dual-Use Technologies
  Platforms with applications across healthcare, security, and defense.

• Organoids & Organ-on-a-Chip Models
  Next-generation preclinical systems transforming translational research and drug development.

• Regulatory Landscape
  Recent FDA announcements on clinical studies and their implications for biotech and life sciences companies.